Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses.
about
Adeno-associated virus type 6 (AAV6) vectors mediate efficient transduction of airway epithelial cells in mouse lungs compared to that of AAV2 vectorsAdeno-associated virus type 2 VP2 capsid protein is nonessential and can tolerate large peptide insertions at its N terminusFollistatin gene delivery enhances muscle growth and strength in nonhuman primatesDifferential activation of innate immune responses by adenovirus and adeno-associated virus vectorsSize does matter: overcoming the adeno-associated virus packaging limitManufacturing of recombinant adeno-associated viral vectors for clinical trialsHomologous recombination mediates functional recovery of dysferlin deficiency following AAV5 gene transferBasal forebrain control of wakefulness and cortical rhythms.Rapid and efficient clearance of blood-borne virus by liver sinusoidal endotheliumAAV-mediated overexpression of human α7 integrin leads to histological and functional improvement in dystrophic miceMethods, potentials, and limitations of gene delivery to regenerate central nervous system cellsRNAi-mediated silencing of estrogen receptor {alpha} in the ventromedial nucleus of hypothalamus abolishes female sexual behaviors.AAV1.NT-3 gene therapy for charcot-marie-tooth neuropathy.Use of real-time polymerase chain reaction to identify cell- and tissue-type-selective peptides by phage display.Genetic fate of recombinant adeno-associated virus vector genomes in muscleAdeno-associated viral vectors engineered for macrolide-adjustable transgene expression in mammalian cells and miceScalable downstream strategies for purification of recombinant adeno- associated virus vectors in light of the properties.Limitations of encapsidation of recombinant self-complementary adeno-associated viral genomes in different serotype capsids and their quantitationAxonal dynamics of excitatory and inhibitory neurons in somatosensory cortex.MicroRNA-29 overexpression by adeno-associated virus suppresses fibrosis and restores muscle function in combination with micro-dystrophinA simplified baculovirus-AAV expression vector system coupled with one-step affinity purification yields high-titer rAAV stocks from insect cellsGenetic vaccines for anthrax based on recombinant adeno-associated virus vectorsPersistent expression of FLAG-tagged micro dystrophin in nonhuman primates following intramuscular and vascular delivery.Targeting human glioblastoma cells: comparison of nine viruses with oncolytic potential.Indirect action of tumor necrosis factor-alpha in liver injury during the CD8+ T cell response to an adeno-associated virus vector in mice.Intrathecal delivery of a mutant micro-opioid receptor activated by naloxone as a possible antinociceptive paradigm.Molecular characterization of adeno-associated viruses infecting childrenCocaine-induced chromatin remodeling increases brain-derived neurotrophic factor transcription in the rat medial prefrontal cortex, which alters the reinforcing efficacy of cocaine.Translation from a DMD exon 5 IRES results in a functional dystrophin isoform that attenuates dystrophinopathy in humans and mice.Gene transfer of human acid sphingomyelinase corrects neuropathology and motor deficits in a mouse model of Niemann-Pick type A disease.Selective reduction of AMPA currents onto hippocampal interneurons impairs network oscillatory activity.A pseudo-plaque method for infectious particle assay and clonal isolation of adeno-associated virus.Generation of neutralizing activity against human immunodeficiency virus type 1 in serum by antibody gene transfer.Comparison of the efficacy of four viral vectors for transducing hypothalamic magnocellular neurosecretory neurons in the rat supraoptic nucleusImmunological aspects of recombinant adeno-associated virus delivery to the mammalian brainImmune responses to adeno-associated virus and its recombinant vectors.Trans-splicing vectors expand the utility of adeno-associated virus for gene therapy.The Epstein-Barr Virus Lytic Protein BZLF1 as a Candidate Target Antigen for Vaccine Development.Defective membrane fusion and repair in Anoctamin5-deficient muscular dystrophy.A translational approach for limb vascular delivery of the micro-dystrophin gene without high volume or high pressure for treatment of Duchenne muscular dystrophy
P2860
Q24529153-798A63A4-45D4-4A18-AC54-30FE1CCCBC65Q24563214-DA643196-8BFB-4772-B5D6-A1F3A61A3E2AQ24598350-F4791FD3-6836-4B04-9C88-3138F48C77B0Q24673796-AE4EFFF4-B61D-4774-9C2A-1913B2DE69B3Q24791052-FDF69013-4A57-42C4-B225-09B0DC333625Q26750799-9F6C6010-C9F9-46AB-B761-5F06F78A9E2AQ27300915-237CB022-D488-4B7F-944D-47E6C78C21F1Q27319516-A511527A-AACF-4155-A6F5-994736A20DD5Q27348854-56CE5431-714D-4F68-A807-3B10D82E7A0AQ28283362-F661FB2E-7185-4AC5-A17E-66FCF5036ED7Q28766660-2795AEC7-4199-4249-9238-8F15DB2422CEQ30477595-D3CB760A-E106-4718-9831-55D59E992E6EQ30573515-F563C872-C5C0-4D7A-8A65-D6180728B9B4Q31139868-C541D2F0-5BD9-4FC0-A66A-EC70BC96A2DDQ33186207-B43FEF55-BF9D-4AA3-9F54-F753FBC4F68EQ33305143-8A5F7871-39B1-4CC8-9C62-35849A9DEAD5Q33555259-BC1F3542-963E-4914-A518-E9AEFF763F8EQ33586309-77A5F497-8C4C-4221-B00D-BC973FB56D2BQ33610037-F1C5BC22-E3E6-48A1-86D3-C2E1F13DDC81Q33631076-BB111F05-A970-4680-94D4-BF04BCE15A22Q33713203-B33D5EDA-2AA5-4CB9-A567-6DD44ADAE624Q33713243-414FDC2A-7998-40F3-B0DC-0C2E62C90DACQ33730464-AD5AD712-02F4-4101-B171-25A9314FB569Q33780536-98161D9A-1270-4B96-B7F4-87D3B3E34BB6Q33855935-3D40CB53-8115-4538-A553-E38E7214919FQ34128898-A9B8C307-B260-48AF-BFCD-9758B2725E5EQ34142840-919068FD-DBEE-4FC9-A0FA-429D972CFC0EQ34145195-DBFC8E91-E63E-46A2-BC08-26D3959E62B8Q34194689-81EDF076-7E25-436B-A182-8A0B2BB3B579Q34202095-6FEC3CC4-E932-42A2-BC7E-ED075EC4D847Q34295573-FDB52E53-E0A3-4638-B6E6-4D26E70E47EFQ34311511-8BD9A8B7-3874-4D08-8B89-C6B52F1912C8Q34344205-FFBB05A0-1C58-4466-A394-BA09E4CCB0A8Q34898869-7DED4CF7-B0E1-497C-AC4B-FC1755FC01BAQ35000819-037E6750-4FD7-4284-8198-2CC8F862DDB3Q35131229-91B5C871-AB49-495B-B819-C1A17B40DBDDQ35799349-F8469EE0-D4AC-4CBA-9224-45152414F312Q35815850-D954A3CF-D1A5-47E0-8FEA-696682670798Q35934667-0A4FA909-8E86-435E-A63B-AB9A7A45950FQ36151226-99C8EB47-EF07-45B5-ABEF-3E2AEB179D04
P2860
Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Highly purified recombinant ad ...... helper and wild-type viruses.
@en
Highly purified recombinant ad ...... helper and wild-type viruses.
@nl
type
label
Highly purified recombinant ad ...... helper and wild-type viruses.
@en
Highly purified recombinant ad ...... helper and wild-type viruses.
@nl
prefLabel
Highly purified recombinant ad ...... helper and wild-type viruses.
@en
Highly purified recombinant ad ...... helper and wild-type viruses.
@nl
P2093
P1433
P1476
Highly purified recombinant ad ...... helper and wild-type viruses.
@en
P2093
P304
P356
10.1089/10430349950018427
P577
1999-04-01T00:00:00Z